Related Experiment Video
Updated: Jun 2, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Two roads diverge: weight loss interventions and circulating amino acids
Robert E Gerszten1, Thomas J Wang
1Cardiology Division and Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital East, Charlestown, MA 02129, USA. rgerszten@partners.org
Science Translational Medicine
|April 29, 2011
Summary
Gastric bypass surgery (GBP) uniquely alters amino acid metabolism, independent of weight loss. This suggests that changes in branched-chain amino acids may improve blood sugar control after GBP.
Area of Science:
- Metabolomics
- Bariatric Surgery
- Endocrinology
Background:
- Weight loss interventions, including gastric bypass surgery (GBP) and dietary changes, impact metabolic health.
- The specific metabolic alterations induced by GBP beyond weight loss remain incompletely understood.
Purpose of the Study:
- To investigate differences in circulating metabolome profiles following equivalent weight loss achieved through GBP versus dietary intervention.
- To identify mechanisms by which GBP may influence metabolic pathways independently of overall weight reduction.
Main Methods:
- Utilized metabolite profiling to analyze changes in the circulating metabolome.
- Compared metabolic profiles between patients undergoing GBP and those adhering to a dietary intervention for weight loss.
Main Results:
- Gastric bypass surgery significantly enhances branched-chain amino acid metabolism.
- These metabolic enhancements occur through mechanisms distinct from those driven solely by weight loss.
- Observed alterations in amino acid metabolism may be linked to improved glycemic control post-GBP.
Conclusions:
- GBP induces specific metabolic changes, particularly in branched-chain amino acid metabolism, that are independent of weight loss.
- These GBP-specific metabolic shifts offer a potential explanation for the rapid improvement in glycemic control seen after surgery.
- Further research into amino acid metabolism could reveal novel therapeutic targets for metabolic disorders.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:18Amino Acid Catabolism
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...